Company Filing History:
1 out of 4 
1 out of 1 
1 out of 832,843 Years Active: 2004-2022
Title: The Innovative Contributions of Tony Antakly
Introduction
Tony Antakly is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that activate nuclear receptors and inhibit histone deacetylases. With a total of 3 patents to his name, Antakly's work has the potential to impact therapeutic practices significantly.
Latest Patents
Among his latest patents, Antakly has developed compositions for the induction of activity of the nuclear receptor PPAR-γ and the inhibition of HDAC. His inventions include a synergistic combination of benzoate and phenylbutyrate and/or phenylacetate, which is associated with a pharmaceutical carrier. These innovations aim to provide therapeutic benefits to subjects in need, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Tony Antakly has worked with various companies, including Altachem Pharma Ltd. His experience in the pharmaceutical industry has allowed him to focus on innovative solutions that address critical health issues. His dedication to research and development has positioned him as a valuable contributor to the field.
Collaborations
Tony Antakly has collaborated with professionals in his field, including Ram M Sairam. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.
Conclusion
Tony Antakly's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.